Dr. Brinda Balakrishnan, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Brinda Balakrishnan, M.D., Ph.D.
Earlier roles on record: Board Member at Aurinia Pharmaceuticals Inc. (AUPH) until September 12, 2024. Aurinia Pharmaceuticals Inc. reported in an 8-K filed September 12, 2024 that Dr. Brinda Balakrishnan, M.D., Ph.D. resigned as Director. Aurinia Pharmaceuticals Inc. reported in an 8-K filed September 12, 2024 that Dr. Brinda Balakrishnan, M.D., Ph.D. resigned as director, effective September 9, 2024.
“The Board has accepted the conditional resignations of Daniel G. Billen, Ph.D., R. Hector MacKay-Dunn, J.D., and Brinda Balakrishnan, M.D., Ph.D., who received less than majority support at the Meeting.”
“the Board, following the deliberation process outlined in the Company's Majority Voting Policy, determined (i) to accept the resignations of Dr. Billen, Mr. MacKay-Dunn, and Dr. Balakrishnan, effective September 9, 2024”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-06-14–2024-09-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.